InvestorsHub Logo
Followers 31
Posts 3757
Boards Moderated 0
Alias Born 01/29/2012

Re: Titan V post# 36059

Friday, 10/07/2016 12:23:59 PM

Friday, October 07, 2016 12:23:59 PM

Post# of 48316
Slide 21 talks about a p2 trial for patients refractory to Keytruda. What are your thoughts on why this trial is needed in addition to existing p2b trial for non-responders to Keytruda. Aren't refractory/non-responding the same thing?